Catalyst
Slingshot members are tracking this event:
Bellicum Pharma (BLCM) to update interim BPX-501 data at European Society for Blood and Marrow Transplantation
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BLCM |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 05, 2016
Occurred Source:
http://ir.bellicum.com/phoenix.zhtml?c=253830&p=irol-newsArticle&ID=2154113
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Bpx-501, Phase 1/2 Data, Blood Cell Disorders, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Non-hodgkin's Lymphoma, Myeloid Leukemia
